Covington Reps As Biogen Makes $1.8B Bet On HI-Bio

By Al Barbarino · May 22, 2024, 12:01 PM EDT

Biogen Inc. said Wednesday it has agreed to purchase Human Immunology Biosciences, or HI-Bio, a San Francisco-based biotechnology company working on targeted therapies for severe autoimmune diseases, in a deal that...

To view the full article, register now.